|
Eligibility for PD Surgery
Eligible for surgery are patients with incomplete effect of medications
on their symptoms and disability and/or patients presenting side effects
due to medication, such as dyskinesias. In general, the sooner the surgery
the better outcome for the patient. High age, although not in itself a
contraindication for operation may increase the risks. Besides, the “old”
patient’s ability for regaining independency after successful surgery
is not as good as that of the “younger” patient. Surgery is contraindicated
in the following conditions:
1. Patients regularly taking anticoagulation drugs or who have blood coagulation
deficiency
2. Severely hypertensive patients with uncontrolled blood pressure
3. Patients with cognitive decline (clinically relevant short-term memory
deficit or dementia)
Pallidotomy and Pallidal DBS
Pathophysiological background: Dopamine deficiency
in the putamen provokes through a GABAergic direct pathway to the globus
pallidus internum (GPI) and a glutaminergic pathway from the subthalamic
nucleus (STN), an over activity of the inhibitory GPI, acting on the thalamo-cortical
circuitry, which provokes an inhibition of movement time and inhibition
of initiation of movements. This inhibition may account for the development
of akinesia, rigidity and tremor in PD. The dyskinesia seen in PD patients
after long duration L-dopa treatment may also be mediated by a dysinhibition
of the STN which provokes a decreased activity of the inhibitory globus
pallidus and hence, the initiation of choreacthetotic movements and dystonias,
ie. dyskinesias.
Indications for surgery: Patients with advanced PD suffering
from on-off phenomena, dystonias, dyskinesias, muscular cramps, tremor,
etc are suitable for surgery on the posteroventral pallidum. There is
an impact profile of pallidal surgery: Dyskinesias respond best, followed
by dystonias and muscular cramps, rigidity, tremor, and akinesia, while
the so called freezing of the gait is worst in responding.(1) If needed,
pallidotomy can be done bilaterally in two separate sessions with a minimum
interval of 6 months between the two surgeries. Bilateral pallidotomy
is contraindicated if there are significant speech or swallowing problems
after the first surgery. The same applies if the patient has moderate
memory problems. The risks of bilateral pallidotomies is decreased if
the lesions are kept within the posteroventral part of the pallidum, avoiding
any encroachment of the lesion on the internal capsule and inclusion of
the antero-dorso-medial pallidum in the lesion.(7,13)
Pallidal DBS on the second side of the brain in patients who have already
had a pallidotomy on one side may be preferred if the patient has significant
speech and voice difficulties.
Side effects: The side effects of pallidotomy in experienced
hands are rare and usually transient. a) Pallidotomy in either hemisphere
may provoke worsening of memory, injury to optic tract, paresis, depression,
stroke, increased salivation. b) Pallidotomy in dominant hemisphere may
provoke confusion, dysarthria, dysphonia. c) Pallidal DBS may be complicated
by infection, skin erosion, displacement of electrode, seroma in pacemaker
pocket, reversible induction of visual, motor, gait and/or speech disturbances.
Results: The results of pallidal surgery depend on which
symptoms are being treated. Furthermore, the degree and longevity of improvement
of the symptoms, dyskinesias excepted, is quite variable. Dyskinesias
decrease markedly in more than 80% of the patients, dystonic pain, muscular
cramps and rigidity in about 70%. Tremor decreases significantly in about
65%.(8) Akinesia diminishes slightly or moderately but freezing of the
gait generally does not improve. After pallidotomy, “on-off” fluctuations
may still occur. However, the “on” periods generally last longer and provide
better mobility without dyskinesias, and the “off” periods usually are
not as profound and as long-lasting as before surgery. Quality of life
is improved.(14) Pallidotomy seems to be more effective, less expensive
and less laborious (for patient and doctor) than pallidal DBS. Unlike
in other brain targets (see below), DBS in the pallidum has less to offer
in terms of increased safety, compared to lesioning, at least when unilateral.
Thalamotomy and Thalamic
DBS
Pathophysiological background: The ventralis intermedius
(VIM) nucleus and, sometimes, the ventralis oralis posterior (VOP) (and
part of the ventralis oralis anterior) nuclei in the ventrolateral thalamus
are the main target area for alleviation of tremor. These nuclei occupy
an area where dentate-thalamic VIM and pallido-thalamic VOP-VOA pathways
converge. These pathways constitute the two adjacent pathways of the so
called extra-pyramidal system: one pathway involves a loop connecting
the following: cerebellar cortex – dentate – nucleus rubber – ventral
thalamus – cerebral cortex - internal capsule – pons nuclei – cerebellar
cortex; the other pathway involves a loop between the caudate – putamen
– pallidum – ventral thalamus – motor cortex – caudate. In the VIM nucleus,
kinaesthetic cells that respond to joint movements and so called tremor
cells synchronous with the tremor are present which are believed to act
as a “pacemaker” to tremor oscillations.
Indications for surgery: The only indication for surgery
on the ventrolateral thalamus is tremor, regardless of origin. Parkinsonian
and essential tremor respond best. Rest and postural tremor respond better
than action tremor. Distal arm tremor responds better than the proximal
one and upper extremity tremor better than lower extremity tremor. Head
and axial tremor respond least and so also ataxia and choreoathetotic
movements and dystonias. Thalamotomy should not be done on both sides
of the brain because of high risks of dysarthria and balance problems.
Thalamic DBS is safer and may be chosen for the dominant brain while thalamotomy
should be reserved for the non-dominant brain.(15) Bilateral thalamic
DBS, however, is also considered quite safe, and has been increasingly
used in the last decade. Thalamotomy on the other hand is nowadays more
rarely done.
Side effects: Thalamotomy does harbour more risks and provokes
more side effects than pallidotomy. Some of the side effects are generally
transient.
a) Thalamotomy in either hemisphere may provoke hyptonia, balance problems,
hemi-inattention, dyspraxia, paresis, dysphonia,
dysphagia, increased bradykinesia, sensory deficit.
b) Thalamotomy in dominant hemisphere may provoke confusion, memory deficit,
dysarthria, dysphonia
c) Thalamic DBS may result in the same complications as for pallidal DBS.
However, in the thalamus there may also be
risk for reversible induction of sensory, motor, gait, speech disturbances,
ataxia or aggravation of akinesia.
Results: a) Thalamotomy provides in 75-85% of the cases
good to excellent results for the tremors. Rigidity is frequently replaced
by hypotonia, that may affect the gait negatively b) Thalamic DBS has
the same figures as above.
DBS of Subthalamic Nucleus
(STN)
Pathophysiological background: In Parkinson’s disease, the
subthalamic nucleus (STN) exerts a strong glutaminergic excitatory effect
on the GPI increasing thus the inhibitory effect of the GPI on movements.
Therefore, the STN is a “logical” target to functionally neutralise (by
chronic high frequency stimulation) in order to alleviate the akinesia
including the freezing of gait in PD.
Indications for surgery: Patients with mainly akinetic symptoms,
and also patients who have motor fluctuations, may benefit from bilateral
simultaneous STN DBS. The STN should not be lesioned by radiofrequency
coagulation because of risk for severe side effects, especially hemiballism
and hypophonia. Therefore, only chronic stimulation with permanently implanted
electrodes is advisable. DBS of the STN is a relatively recent procedure.
Its long-term efficacy is not yet established nor its safety in terms
of remote side effects, despite the fact that it is widely used nowadays.
In the following will be listed what is already known about that surgery.
Side effects: Confusion, mostly transient, is frequently
seen after bilateral STN DBS.(11) Also dysphonia and dysarthria may not
be as uncommon as previously thought. Difficulties in opening eyelids,
personality changes and thought disorders have also been mentioned (Volkmann
J: Deep brain stimulation of globus pallidus internus and sub-thalamic
nucleus in advanced Parkinson’s disease. Presentation of the results of
the multicenter DBS in advanced Parkinson’s disease study at the Kinetra
Launch meeting, Lausanne, Switzerland, February 4, 2000). The possible
induction of dyskinesias, it not truly a side effect because after successful
STN stimulation, the doses of L-dopa medication can often be reduced in
most patients.(11)
Results: So far, it seems, that STN DBS benefits mostly
for the akinetic patients, especially patients with gait freezing. In
fact, it seems that this is the most powerful surgical procedure for genuine
symptoms of PD, including the gait freezing, and it also affects positively
the rigidity and the tremor as well.
Conclusion
Stereotactic surgery for Parkinson’s disease is, in experienced hands,
a relatively safe operation. Surgery should be proposed for patients well
before they reach end-stage of the disease and/or start to show signs
of dementia. This would provide the patients with many years of improved
quality of life despite the course of their chronic and progressive illness.
The choice of brain target to be lesioned or stimulated should be based
on the analysis of the evolution of the specific symptoms of each patient
and based on which impact these symptoms have on the disability of the
patient. For patients with advanced PD, pallidotomy or STN DBS seems most
appropriate. However, depending on bilaterally of symptoms, on availability
of stimulators, on costs, and on availability of close follow-up of patients,
one may choose between these two procedures, keeping in mind that pallidotomy
is often done unilaterally and affects immediately, mainly but not solely,
dyskinesias, while STN DBS can be done simultaneously bilateral and acts
mainly on gait freezing and rigidity, but requires frequent and laborious
follow-up before it reaches its full effect. In those (rare) patients
with stable PD and where the tremor is the only symptom, or in patients
where a previous pallidal (or STN) surgery did not affect the tremor,
then radio-frequency lesion, or, rather, DBS in the ventro lateral thalamus
may be indicated. Table 1 shows the characteristics, effects and side
effect of the various procedures.
|
| 1. |
Baron MS, Vitek JL, Bakay RA, Green
J, McDonald WM, Cole SA, DeLong MR: Treatment of advanced Parkinson’s
disease by unilateral posterior Gpi pallidotomy: 4-year results
of a pilot study. Mov Disord, 15: 230-237 |
| 2. |
Carrol CB, Scott R, Davies LE, Aziz
T: The pallidotomy debate. BJN 1998, 12: 146-150 |
| 3. |
de Bie RM, de Haan RJ, Nijssen PC,
Rutgers AW, Beute GN, Bosch DA, Haxma R, Schmand B, Schuurman PR,
Staal MJ, Speelman JD: Unilateral pallidotomy in Parkinson’s disease:
A randomised, single-blind, multicentre trial. Lancet 1999, 354:
1665-1669 |
| 4. |
Hallett M, Litban I: Evaluation of
surgery for Parkinson’s disease: A report of the Therapeutics and
Technology Assessment Subcommittee of the American Academy of Neurology.
The Task Forces on Surgery for Parkinson’s Disease. Neurol 1999,
53: 1910-1921 |
| 5. |
Hariz MI, Bergenheim AT, Fodstad H:
Crusade for micoelectrode guidance in pallidotomy. Letter to the
Editor. J Neurosurg 1999, 90: 175-177 |
| 6. |
Hariz MI, Fodstad H: Do
microelectrode techniques increase accuracy or decrease risks in
pallidotomy and deep brain stimulation? A critical review of the
literature. Stereotact Funct Neurosurg 1999, 72: 157-169 |
| 7. |
Hariz MI: Complications of movement
disorder surgery and how to avoid them. In: Lozano A: Progress in
Neurological Surgery, Vol 15, Basel, Karger 2000, pp 246-265 |
| 8. |
Johansson F, Malm J, Nordh E, Hariz
M: Usefulness of pallidotomy in advanced Parkinson’s disease. J
Neurol Neurosurg Psych 1997, 62: 125-132 |
| 9. |
Krack P, Hamel W, Mehdorn HM, Deuschl
G: Surgical treatment of Parkinson’s disease. Curr Opin Neurol 1999,
12: 417-425 |
| 10. |
Laitinen LV, Bergenheim AT, Hariz MI:
Leksell’s posteroventral pallidotomy in the treatment of Parkinson’s
disease. J Neurosurg 1992, 76: 53-61 |
| 11. |
Limousin P, Krack P, Pollak P, Benazzouz
A, Ardouin C, Hoffmann D, Benabid AL: Electrical stimulation of
the subthalamic nucleus in advanced Parkinson’s disease. New Eng
J Med 1998, 339: 1105-1111 |
| 12. |
Limousin-Dowsey P, Pollak P, VamBlercom
N, Krack P, Benazzouz A, Benabid A: Thalamic, subthalamic nucleus
and internal pallidum stimulation in Parkinson’s disease. J Neurol
1999, 246 (Suppl) 2:II: 42-45 |
| 13. |
Lombardi WJ, Gross RE, Trepanier LL,
Lang AE, Lozano AM, Saint-Cyr JA: Relationship of lesion location
to cognitive outcome following microelectrode-guided pallidotomy
for Parkinson’s disease: Support for the existence of cognitive
circuits in the human pallidum. Brain 2000, 123: 746-758 |
| 14. |
Martinez-Martin P, Valldeoriola
F, Molinuevo JL, Nobbe FA, Rumia J, Tolosa E: Pallidotomy and quality
of life in patients with Parkinson’s disease: An early study. Mov
Disord 2000, 15: 65-70 |
| 15. |
Schuurman PR, Bosch DA, Bossuyt PM,
Bonsel GJ, van Someren EJ, de Bie RM, Merkus MP, Speelman JD: A
comparison of continuous thalamic stimulation and thalamotomy for
suppression of severe tremor. N Eng J Med 2000, 342: 461-468 |
| 16. |
Vitek JL, Bakay RA, Hashimoto T, Kaneoke
Y, Mewes K, Yu Zhang J, Rye D, Starr P, Baron M, Turner R, Delong
MR: Microelectrode-guided pallidotomy: technical approach and its
application in medically intractable Parkinson’s disease. J Neurosurg
1998, 88: 1027-1043 |
|